Limited-stage diffuse large B-cell lymphoma
EA Hawkes, A Barraclough… - Blood, The Journal of the …, 2022 - ashpublications.org
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoma subtype, is localized
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
Limited-stage diffuse large B-cell lymphoma
EA Hawkes, A Barraclough, LH Sehn - Blood, 2022 - research.monash.edu
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoma subtype, is localized
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
Limited-stage Diffuse Large B-cell Lymphoma.
EA Hawkes, A Barraclough, LH Sehn - 2022 - ahro.austin.org.au
DLBCL, the most common lymphoma subtype, is localized in 25-30% of patients. Prognosis
in patients with limited-stage DLBCL (LS-DLBCL) is excellent with 10-year overall survival of …
in patients with limited-stage DLBCL (LS-DLBCL) is excellent with 10-year overall survival of …
[HTML][HTML] Limited-stage diffuse large B-cell lymphoma
EA Hawkes, A Barraclough, LH Sehn - Blood, 2022 - Elsevier
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoma subtype, is localized
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
[PDF][PDF] Limited-stage diffuse large B-cell lymphoma
EA Hawkes, A Barraclough, LH Sehn - blood, 2022 - researchgate.net
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoma subtype, is localized
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
Limited-stage diffuse large B-cell lymphoma
EA Hawkes, A Barraclough, LH Sehn - Blood, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Diffuse large B-cell lymphoma (DLBCL), the
most common lymphoma subtype, is localized in 25% to 30% of patients. Prognosis in …
most common lymphoma subtype, is localized in 25% to 30% of patients. Prognosis in …
Limited-stage diffuse large B-cell lymphoma.
EA Hawkes, A Barraclough, LH Sehn - Blood, 2022 - europepmc.org
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoma subtype, is localized
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
Limited-stage diffuse large B-cell lymphoma
EA Hawkes, A Barraclough, LH Sehn - Blood, 2022 - pubmed.ncbi.nlm.nih.gov
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoma subtype, is localized
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …
in 25% to 30% of patients. Prognosis in patients with limited-stage DLBCL (LS-DLBCL) is …